unknown
Stage
1
Investors
About
Axithra is developing a photonics-based point-of-care device that uses Raman spectroscopy on a chip to rapidly detect and quantify the active (free) fraction of drugs in patient blood for therapeutic drug monitoring. The technology is under development and clinical investigation and is not yet FDA cleared or CE-marked.
Explore Axithra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.